Skip to main content
Log in

Pharmacokinetics of midazolam in critically ill neonates

  • Short Communications
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Midazolam is a water soluble benzodiazepine, with a short elimination half-life in adults and children. An IV bolus of midazolam 0.2 mg · kg−1 was administered to 10 critically ill neonates receiving intensive care who required sedation.

The plasma clearance was 6.85 ml · min−1 and the elimination half-life was 6.52 h. Midazolam was well tolerated during and after administration.

Because of its short half-life compared to diazepam, midazolam could be used during the neonatal period to produce brief rapid sedation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Anand KJS, Hickey PR (1987) Pain and its effects in the human neonate and foetus. N Engl J Med 9: 1321–1329

    Google Scholar 

  2. Willatts SM (1985) Intravenous sedation by infusion on the intensive care unit. Br J Parent Ther 1: 13–17

    Google Scholar 

  3. Farina ML, Levati A, Tognoni G (1981) A multi-center study of intensive care drug utilisation. Intensive Care Med 7: 125–131

    Google Scholar 

  4. Morselli PL, Principi N, Tognoni G, Reali E, Belvedere G, Standen S, Sereni F (1973) Diazepam elimination in premature and full-term infants and children. J Perinat Med 1: 133–141

    Google Scholar 

  5. Olive G, Rey E (1982) Pharmacocinétique comparée des benzodiazépines. Nouv Presse Med 11: 2957–2964

    Google Scholar 

  6. Reves JG, Fragen R, Vinik HR, Greenblatt DJ (1985) Midazolam: pharmacology and uses. Anesthesiology 62: 310–324

    Google Scholar 

  7. Saint-Maurice C, Meistelman C, Rey E, Esteve C, De Lauture D, Olive G (1986) The pharmacokinetics of rectal midazolam for premedication in children. Anesthesiology 65: 536–538

    Google Scholar 

  8. Booker PD, Beechey A, Lloyd-Thomas AR (1986) Sedation of children requiring ventilation using an infusion of midazolam. Br J Anaesth 58: 1104–1108

    Google Scholar 

  9. Puglisi CV, Pao J, Ferrara FJ, de Silva JAF (1985) Determination of midazolam (Versed) and its metabolites in plasma by high-performance liquid chromatography. J Chromatogr 344: 199–209

    Google Scholar 

  10. Allonen H, Ziegler G, Klotz U (1981) Midazolam kinetics. Clin Pharmacol Ther 30: 653–661

    Google Scholar 

  11. Payne K, Mattheyse FJ, Liebenberg D, Dawes T (1989) The pharmacokinetics of midazolam in paediatric patients. Eur J Clin Pharmacol 37: 267–272

    Google Scholar 

  12. Aranda JV, MacLeod SM, Renton KW, Eade NR (1974) Hepatic microsomal drug oxidation and electron transport in newborn infants. J Pediatr 85: 534–542

    Google Scholar 

  13. Guignard JP, Torrado A, Da Cunha O, Gautier F (1975) Glomerular filtration rate in the first weeks of life. J Pediatr 87: 268–272

    Google Scholar 

  14. Morselli PL, Franco-Morselli R, Bossi L (1980) Clinical pharmacokinetics in newborns and infants: age-related differences and clinical implications. Clin Pharmacokinet 5: 485–527

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jacqz-Aigrain, E., Wood, C. & Robieux, I. Pharmacokinetics of midazolam in critically ill neonates. Eur J Clin Pharmacol 39, 191–192 (1990). https://doi.org/10.1007/BF00280059

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00280059

Key words

Navigation